MONDAY, MAY 22, 2017

U.S. man in Taiwan contracts tularemia

Taiwan Read More »

New vaccine to fight chikungunya virus developed

Researchers have developed a new vaccine candidate to treat chikungunya virus, a mosquito-borne pathogen that produces an intensely painful and chronic arthritic disease. Read More »

Microwaves could be used to fight malaria

Researchers from one of Panama's top research institutes and Penn State University have developed a technique that may allow full-body microwave scanners to cure malaria. Read More »

Dengue fever numbers rising in the Philippines

According to health officials in the Philippines, the country has experienced more than 46,000 cases of mosquito-borne dengue in the last seven months. Read More »

Cholera epidemic spreading through Somalia

A cholera epidemic is spreading throughout Somalia as thousands flee famine hit areas for crowded refugee camps. Read More »

Mortality rate for H5N1 lowers over the last five years

A recent study by German scientists has shown that the global mortality rate of H5N1 avian influenza has declined somewhat in the last 5 years. Read More »

New Zealand measles outbreak grows to 120

An outbreak of measles that has infected more than 120 people in the upper North Island of New Zealand is continuing to spread. Read More »

Maryland health officials push for hospital worker flu vaccinations

While Maryland hospitals have become more aggressive in recent years about vaccinating workers for the flu, public health officials are pushing for stricter programs to halt the spread of the flu virus. Read More »

National Institutes of Health study adds dengue, TB and H1N1 models

The National Institutes of Health Read More »

IDRI to develop new malaria vaccine

The Infectious Disease Research Institute recently announced that it has agreed upon a memorandum of understanding with the United States Agency for International Development to help with the development of a new malaria vaccine. Read More »

GeoVax receives HIV vaccine grant

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing HIV vaccines, received a $3.6 million annual Integrated Preclinical/Clinical AIDS Vaccine Development grant award on Tuesday. Read More »

NexBio's Fludase influenza vaccine shows promising results

NexBio's lead drug candidate Fludase has shown encouraging results in a Phase 2 clinical trial by significantly reducing the amount of influenza virus in patients receiving the drug compared to those who took a placebo. Read More »

Connection found between obesity, flu complications

A new study recently revealed a connection between obesity and respiratory hospitalizations during seasonal flu months. Read More »

Mosquitoes gaining resistance to anti-malaria insecticides

According to a new study conducted in Senegal, the species of mosquito that commonly spreads malaria in Africa is developing increasing resistance to previously effective insecticides. Read More »

Bacteria re-engineered to fight drug-resistant microbe

A research team in Singapore has re-engineered a strain of harmless bacteria to fight against another common, drug-resistant microbe that can be deadly to hospital patients with weak immune systems. Read More »

Microcalorimeters used to rapidly diagnose TB

Scientists have recently developed a more efficient means to diagnose tuberculosis that relies on the use of microcalorimeters, which measure the heat given off from bacteria as they grow. Read More »

Co-infection of TB and parasitic worms may complicate treatment

Research conducted at the University of Medicine and Dentistry of the New Jersey Medical School has established that the co-infection of tuberculosis and parasitic worms can complicate TB treatment. Read More »

CDC urges flu everyone to receive flu shot

Although the influenza strains included in the upcoming season's trivalent vaccine remain the same from last season, the Centers for Disease Control and Prevention continues to recommend vaccinations for everyone older than six months. Read More »

Imaging tech. may identify pandemics and their cause

The Methodist Hospital Research Institute and Philips Healthcare are developing imaging technology that can be used to identify when an epidemic will begin and, potentially, what causes it. Read More »

Imaging tech. may identify pandemics and their cause

The Methodist Hospital Research Institute and Philips Healthcare are developing imaging technology that can be used to identify when an epidemic will begin and, potentially, what causes it. Read More »